Wednesday, December 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

ZipRecruiter Stock: Analysts Slash Targets Amid Market Woes

Robert Sasse by Robert Sasse
August 12, 2025
in Stocks
0
ZipRecruiter Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

ZipRecruiter faces mounting challenges as two major banks significantly cut their price targets, reflecting growing skepticism about the job platform’s near-term prospects. Goldman Sachs and JPMorgan reduced their valuations to $5 from $7, though even this appears ambitious with the stock languishing near $3.48—a 52-week low. Year-to-date, shares have plummeted over 50%, while revenue shrunk 21% annually. Despite beating Q2 revenue expectations ($112.2M vs. $111.74M forecast), the company posted a $9.5M net loss, triggering a 13% after-hours drop. Analysts blame macroeconomic headwinds, noting employers’ hiring caution directly undermines ZipRecruiter’s core business.

Glimmers of Hope Amid Struggles

Management points to sequential revenue growth—the first since 2021—and optimism for Q4 recovery, particularly in healthcare and education sectors. AI tools like "ZipIntro" saw 90% quarterly usage growth, though broader AI disruption remains minimal. The company bolstered its buyback program by $100M, signaling confidence, and maintains an 89.5% gross margin. However, analysts remain neutral, awaiting sustained double-digit growth and progress toward its long-term 30% EBITDA margin goal. With paying employers up 4% to 66,300 but revenue per employer declining, pricing pressures persist, leaving investors wary of a turnaround.

Ad

ZipRecruiter Stock: Buy or Sell?! New ZipRecruiter Analysis from December 31 delivers the answer:

The latest ZipRecruiter figures speak for themselves: Urgent action needed for ZipRecruiter investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 31.

ZipRecruiter: Buy or sell? Read more here...

Tags: ZipRecruiter
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Microsoft Stock

Microsoft Stock: GitHub CEO Exit Signals AI Strategy Shift

Gerresheimer Stock

Gerresheimer Stock: Leadership Shake-Up Sparks Investor Watch

Apple Stock

Apple Stock: Musk Threatens Legal Action Over AI Bias

Recommended

Healthcare Services Stock

Healthcare Services Group Stock: Navigating a Data Breach Amidst Analyst Optimism

3 months ago
TAG Immobilien Stock

TAG Immobilien Stock: Strong Turnaround Fuels Growth

5 months ago
AMD Stock

Advanced Micro Devices: A Puzzling Market Reaction to Record Performance

2 months ago
Apple Stock

Apple Faces Potential $38 Billion Regulatory Challenge

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Future Fuels Shares Under Pressure Amid Widening Losses

Netflix Shares Under Pressure Amid Landmark Acquisition Bid

Institutional Investors Accumulate PayPal Shares Amid Market Uncertainty

A Diverging Path: BYD’s Strategic Gains Contrast with Tesla’s Setbacks

XRP at a Crossroads: Institutional Demand Battles Whale Selling Pressure

Nasdaq 100 Set for a Subdued Year-End Finish

Trending

BioNTech Stock
Analysis

BioNTech’s Strategic Pivot: Building Beyond the COVID-19 Windfall

by Robert Sasse
December 31, 2025
0

Despite a challenging year for its share price, BioNTech concludes 2025 in a stronger strategic and financial...

DroneShield Stock

DroneShield Shares Surge on Robust Year-End Contract Momentum

December 31, 2025
MSCI World ETF Stock

The MSCI World ETF’s Ascent: A Record-Breaking Year Fueled by Tech

December 31, 2025
Future Fuels Stock

Future Fuels Shares Under Pressure Amid Widening Losses

December 31, 2025
Netflix Stock

Netflix Shares Under Pressure Amid Landmark Acquisition Bid

December 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Strategic Pivot: Building Beyond the COVID-19 Windfall
  • DroneShield Shares Surge on Robust Year-End Contract Momentum
  • The MSCI World ETF’s Ascent: A Record-Breaking Year Fueled by Tech

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com